August, 2023

article thumbnail

Medicare names first 10 drugs for price negotiations

BioPharma Drive: Drug Pricing

The list includes the top-selling blood thinners Eliquis and Xarelto, as well as the arthritis drug Enbrel and heart failure medicine Entresto.

Drugs 120
article thumbnail

Pharma maintains high level of trust from UK public and doctors

Drug Discovery World

The pharmaceutical industry continues to maintain strong levels of public trust and favourability in the UK, according to data from the Association of the British Pharmaceutical Industry (ABPI). Opinions showed consistent recognition of the sector’s support for the NHS, with 67% of respondents saying the industry is committed to developing new medicines to meet patient needs.

Doctors 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Evolved prime editors are smaller and more efficient for therapeutic applications

Broad Institute

Evolved prime editors are smaller and more efficient for therapeutic applications By Corie Lok August 31, 2023 Breadcrumb Home Evolved prime editors are smaller and more efficient for therapeutic applications Researchers have evolved the editing machine at the heart of the prime editing system, which can make a wide range of changes to the genome. By Sarah C.P.

DNA 145
article thumbnail

Marijuana Should Be Moved to Lower-Risk Drug Category, U.S. Health Officials Say

Drugs.com

THURSDAY, Aug. 31, 2023 – The U.S. Department of Health and Human Services has asked the U.S. Drug Enforcement Agency to reclassify marijuana as a less dangerous drug under the Controlled Substances Act, a move that could potentially expand.

Drugs 122
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Why participating in research can be a rewarding experience

Antidote

At the outset, many people may experience apprehension when considering joining a clinical trial. Opting to participate in a research study is a personal one — but it can also be quite gratifying. Various types of clinical studies play a pivotal role in ensuring the approval of life-saving medications and treatments. For this to happen, we need volunteers to take part.

Research 119
article thumbnail

Kotlin Tutorial | Kotlin Programming Language for beginners

Perficient: Drug Development

Responsibilities, Skills, Scope and More. The tutorial provides basic concepts of Kotlin. Our Kotlin tutorial includes. What is Kotlin? Pre-Requisites Features of Kotlin Kotlin Architecture What is Kotlin? Kotlin is a programming language introduced by JetBrains in 2011. Kotlin is free, has been free and will remain free. It is developed under the Apache 2.0 license.

Licensing 105

More Trending

article thumbnail

Meet the researcher: Giusy Di Conza

Drug Discovery World

DDW’s Megan Thomas looks at a day in the life of Giusy Di Conza , Head of Research at iOnctura. MT: Where do you work, and can you tell us what you’re working on at the moment? GDC : I’m Head of Research for a young, dynamic biotech called iOnctura. We are pioneering research into new biological mechanisms for established drug targets. Whereas traditionally biotechs have studied the effect of a drug on a singular pathway, we are focused on targets that are involved in multiple independent tumour

Research 246
article thumbnail

Stem cell therapy: Alzheimer’s disease symptoms

Drug Target Review

In the pursuit of a remedy for Alzheimer’s disease, a frontier in medical science is illuminating a glimmer of hope. Stem cell therapies have already demonstrated their prowess in treating diverse cancers and ailments linked to the blood and immune system. In an innovative proof-of-concept investigation, researchers at the University of California San Diego have revealed the potential of stem cell transplants as a promising therapeutic avenue against Alzheimer’s disease.

Disease 105
article thumbnail

Opioid OD Rescue Drug Narcan Will Reach Drug Store Shelves Next Week

Drugs.com

WEDNESDAY, Aug. 30, 2023 -- Narcan, a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week. People who want to carry Narcan, the nasal spray version of naloxone, will be able.

Drugs 122
article thumbnail

Bayer Crop Science 2023 Grants4Ag Awardees

Translation

Halo was proud to host Bayer Crop Science ’s third year of Grants4Ag. Grants4Ag is Bayer’s annual initiative providing funding and expertise to researchers developing novel solutions in agriculture. As part of Bayer’s CropKey approach to crop protection innovation, this year’s awards focused on transformative R&D and breakthrough technologies for next-gen crop protection solutions.

Science 98
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Using Feign Client in Spring Boot: Simplifying Microservice Communication

Perficient: Drug Development

Introduction to Feign Client: In the world of software, microservices are like building blocks that help make programs more flexible and scalable. But for these blocks to work together, they need to talk to each other effectively. Imagine each block sharing information, asking for help, and working together smoothly. Meet Feign Client, a super useful tool for microservices.

Packaging 105
article thumbnail

Bristol Myers gets key FDA approval for bone marrow disease drug

BioPharma Drive: Drug Pricing

A broadened clearance for Reblozyl in myelodysplastic syndromes should help Bristol Myers offset the looming loss of revenue from top-selling medicines set to soon lose market exclusivity.

article thumbnail

Horizon Europe delay damaging UK’s reputation as a science leader

Drug Discovery World

As negotiations continue between the UK and EU over Horizon Europe, the largest collaborative research programme in the world, the scientific research community has urged the Prime Minister to secure the UK’s membership as soon as possible. Figures reported in The Guardian from the European Commission emphasise the importance of the programme to UK research.

Science 246
article thumbnail

Fourteen HP&M Attorneys Recognized by Best Lawyers® in 2024 in America

FDA Law Blog: Biosimilars

Hyman, Phelps & McNamara, P.C. (“HP&M”) is is proud to announce that 14 of the Firm’s attorneys have been selected to the 2024 edition of The Best Lawyers in America®. Newly recognized this year are attorneys Josephine M. Torrente (FDA Law), Michelle L. Butler (FDA Law), Sara W. Koblitz (FDA Law), Allyson B. Mullen (FDA Law), and Anne K. Walsh (FDA Law), as well as McKenzie E.

FDA 98
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Cardiac Arrest: Many People Experience Warning Signs the Day Before

Drugs.com

WEDNESDAY, Aug. 30, 2023 -- Sudden cardiac arrest may not come on so suddenly after all. Fully 50% of people who experienced a sudden cardiac arrest had a telling symptom 24 hours before, and these symptoms are different in men than women, a new.

111
111
article thumbnail

What happens in each clinical trial phase? [infographic]

Antidote

Before any new treatment is able to be approved, it is required to go through the vigorous testing process known as clinical trials. These trials are aimed at determining whether or not a drug, medical device, therapy, or other type of intervention is safe and effective for the public.

article thumbnail

The Innovation Wildcard – Surprise Yourself!

Perficient: Drug Development

An innovation wildcard is a team member who is there to add a unique perspective that the rest of the team may not have. This person can be within the organization or pulled from outside. They may have deep expertise in other areas, or they may be new and more likely to question everything. Innovation demands new ideas and ways of thinking. Adding a wildcard player to the team will help the creativity process.

article thumbnail

Sage, reeling from depression drug decision, to lay off 40% of workforce

BioPharma Drive: Drug Pricing

Two founding executives are leaving Sage alongside a major restructuring announced weeks after the FDA approved the medicine, Zurzuvae, for much narrower use than the company had hoped.

article thumbnail

UK biotech financing up 29% on last quarter

Drug Discovery World

The second quarter of 2023 has seen steady growth in financing activity for the UK’s life sciences sector, according to new data released by the BioIndustry Association (BIA) and Clarivate. The positive news comes soon after industry figures welcomed recent announcements to unlock new sources of capital in the City of London. Last month, the UK Chancellor and the Lord Mayor of London launched Mansion House Compact, which is an agreement by pension providers to allocate a minimum 5% to unlisted e

Science 246
article thumbnail

Cancer immunotherapy: GDF-15’s role in Anti-PD-1 resistance

Drug Target Review

The focus of this study is on Growth Differentiation Factor-15 (GDF-15), a cytokine known for its critical role in feto-maternal tolerance, which has now been found to be hijacked by tumours to evade immune attack. We will explore how GDF-15 impacts the tumour microenvironment and hinders the infiltration of T cells into the tumour, as well as the implications of neutralising GDF-15 to reverse its inhibitory effects and sensitise tumours to anti-PD-1 treatment.

article thumbnail

Poorer Neighborhoods Linked to Higher Asthma Rates in Kids

Drugs.com

THURSDAY, Aug. 31, 2023 -- When factoring in why children get asthma, a child's neighborhood may be important to consider. New research finds that living in a neighborhood during early childhood that has better access to resources was associated.

Research 111
article thumbnail

Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry

Drug Patent Watch

Loss of exclusivity (LOE) doesn’t have to spell doom for branded drug revenue streams. In the face of impending patent expirations, pharmaceutical companies can adopt key approaches to preserve meaningful… The post Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Six Challenges to Navigate When Shifting From Wholesale to Direct-to-Consumer Models

Perficient: Drug Development

The transition from a wholesale-centric business model to include a new direct-to-consumer (D2C) approach presents lucrative opportunities alongside a suite of technical and operational intricacies to consider. While the move brings manufacturing companies closer to end consumers, it also requires several considerations spanning content creation, post-purchase support, and overall brand experience.

article thumbnail

Apellis finds faulty needles in probe of rare eye drug side effects

BioPharma Drive: Drug Pricing

The company doesn’t know if the needles have caused retinal vasculitis in some people receiving its geographic atrophy drug Syfovre, but is no longer recommending their use.

Drugs 98
article thumbnail

Astex and MSD expand cancer drug discovery collaboration

Drug Discovery World

Astex Pharmaceuticals and MSD (Merck & Co) have announced an exclusive worldwide research collaboration to identify small molecule candidates with activity towards a tumour suppressor protein for the treatment of cancer. Under the terms of the agreement, Astex will apply its fragment-based drug discovery platform to develop compounds targeting multiple forms of the p53 tumour suppressor protein and provide MSD with lead compounds for further optimisation and preclinical development.

article thumbnail

#WhyIScience Q&A: A computational biologist helps build datasets for genetic disease diagnosis

Broad Institute

#WhyIScience Q&A: A computational biologist helps build datasets for genetic disease diagnosis By Corie Lok August 17, 2023 Breadcrumb Home #WhyIScience Q&A: A computational biologist helps build datasets for genetic disease diagnosis Katherine Chao talks about her work managing the Genome Aggregation Database (gnomAD) and the importance of diverse datasets in rare disease diagnosis.

Disease 98
article thumbnail

Poll: Only Half of Older Adults Have Heard of the New RSV Vaccines, Arexvy and Abrysvo

Drugs.com

MONDAY, Aug. 28, 2023 -- About half of older adults (52 percent) have heard of the new vaccines against respiratory syncytial virus (RSV), Arexvy and Abrysvo, according to the National Poll on Healthy Aging released online on Aug. 22.

Vaccine 111
article thumbnail

Carrier receives International Award for Outstanding Leadership

SCIENMAG: Medicine & Health

Julie Carrier, professor and head of the University of Tennessee Department of Biosystems Engineering and Soil Science, was awarded the James R. and Karen A. Gilley Academic Leadership Award during the annual international meeting of the American Society of Agricultural and Biological Engineers (ASABE) in July.

article thumbnail

New patent for United Therap drug REMODULIN

Drug Patent Watch

Annual Drug Patent Expirations for REMODULIN Remodulin is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are nine patents… The post New patent for United Therap drug REMODULIN appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

Foundery, a new biotech venture firm, sets out to speed early immune drug research

BioPharma Drive: Drug Pricing

Billing itself as both a scientific and investment partner, Foundery aims to provide research grants and drug development support to researchers developing new immunotherapies.

article thumbnail

Scientists create compound that can block cancer metastasis

Drug Discovery World

Researchers from the University of Liverpool, UK, have created a biomedical compound that has the potential to stop the spread of breast cancer. Scientists from the Chemistry and Biochemistry Departments at the University of Liverpool and Nanjing Medical School in China have discovered a possible way to block proteins that cause metastasis. The major problem hindering the successful treatment of commonly occurring cancers is not the primary tumour which can usually be removed by surgery, but its

article thumbnail

What is primary sclerosing cholangitis (PSC)?

Antidote

Primary sclerosing cholangitis (PSC) is a condition that impacts the bile ducts of the liver, causing them to become inflamed and ultimately scar. It primarily affects young and middle-aged men, and 80% of patients with PBC also have inflammatory bowel disease (IBD).

Disease 98
article thumbnail

Do Most Americans Know How to Help Loved Ones Battling Addictions? New Poll Says Yes

Drugs.com

THURSDAY, Aug. 31, 2023 -- If a loved one were living with addiction, a majority of Americans say they would know how to get help. About 71% of 2,200 respondents to an American Psychiatric Association poll said they would know how to assist a friend.

111
111
article thumbnail

Innovative projects answer NIDA’s challenge to implement substance use prevention in primary care

National Institute on Drug Abuse: Nora's Blog

Innovative projects answer NIDA’s challenge to implement substance use prevention in primary care astewart Mon, 08/14/2023 - 10:04 Nora's Blog August 22, 2023 Image ©Getty Images/ Maskot With nearly 110,000 people dying from drug overdoses last year, the crisis has not abated. We have effective treatments for opioid and other drug use disorders, but growing numbers of people are dying from fentanyl even in the absence of a substance use disorder—for instance, young people overdosing on fentanyl-

Vaccine 98